Dr Arielle Selya presents a review of the common flaws in observational research on e-cigarette use and discusses the impact that these flaws have on study conclusions. Dr Selya offers suggestion on how furture studies in the field could be improved. #GFN25ScienceLab
youtu.be/z2jdxsSlbLo

In today's #GFN25ScienceLab session, Dr Layla Malt presents findings from two behavioural studies conducted among UK adult smokers. It tracks product use over time and efficacy for smoking cessation, and also examined the role of flavours.
youtu.be/7RgbPWgJ6Q8

Sam Hampsher-Monk (ARAC) explores how person-centered thinking applies to the global nicotine and tobacco policy landscape. He explains how effective THR depends not only on the availability of safer alternatives but also on evidence-based messaging. #GFN25ScienceLab

During #GFN25, Todd Prochnau presented a pharmacist's review of Canadian guidance on alcohol consumption and how the principles of patient-centred care and informed decision making can be applied to both alcohol and nicotine products. #GFN25ScienceLab

In our next Science Lab session Dr Marewa Glover presents the key findings of the Voices of the 5% Study, a 4-year longitudinal qualitative study of New Zealand adults who used vapes but had no intention of quitting smoking. #GFN25ScienceLab

Today in #GFN25ScienceLab discussion, Roberto Sussman provides a critiques of e-cigarette aerosol studies and discusses the methodological problems that persist with emission studies, such as overheating coils to produce aldehydes and manufacturing harms.

Misunderstanding nicotine delivery: a discussion on nicotine pouches. PMI's Carrie Wade and Gizelle Baker discuss the problems with comparing nicotine content of pouches with combustible tobacco. #GFN25ScienceLab